# FDA 483 - Manohar L. Jethani, MD - February 05, 2026

Source: https://www.keypedia.com/records/483/manohar-l-jethani-md/a506a8f0-3616-41aa-803f-749cb267124f

> FDA 483 for Manohar L. Jethani, MD on February 05, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Manohar L. Jethani, MD
- Inspection Date: 2026-02-05
- Product Type: drugs
- Office Name: FDA District Office — Chicago, Illinois
- Summary: Manohar L. Jethani, MD, a clinical investigator in Oak Brook, IL, was cited for two significant issues during an FDA inspection. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan, specifically regarding laboratory testing procedures and sample collection. Additionally, the firm did not obtain informed consent from human subjects prior to initiating study-related screening procedures, violating federal regulations.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/yuanyuan-li/2043568b-a6ac-4f49-8018-c2c8edda8ac5)

Company: https://www.keypedia.com/companies/manohar-l-jethani-md/44d06262-0abb-435a-b4f8-eb4b474c33cd

Office: https://www.keypedia.com/offices/fda-district-office-chicago-illinois/62c2811c-10c5-4d74-99d0-eb5047ef3b65